Global Anti-inflammatory Biologics Sales Market Report 2021
1 Anti-inflammatory Biologics Market Overview
- 1.1 Anti-inflammatory Biologics Product Scope
- 1.2 Anti-inflammatory Biologics Segment by Type
- 1.2.1 Global Anti-inflammatory Biologics Sales by Type (2016 & 2021 & 2027)
- 1.2.2 Synthetic Type
- 1.2.3 Biological Type
- 1.3 Anti-inflammatory Biologics Segment by Application
- 1.3.1 Global Anti-inflammatory Biologics Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Arthritis
- 1.3.3 Respiratory Diseases
- 1.3.4 Dermatology
- 1.3.5 Gastroenterology
- 1.3.6 Others
- 1.4 Anti-inflammatory Biologics Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Anti-inflammatory Biologics Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Anti-inflammatory Biologics Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Anti-inflammatory Biologics Price Trends (2016-2027)
2 Anti-inflammatory Biologics Estimates and Forecasts by Region
- 2.1 Global Anti-inflammatory Biologics Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Anti-inflammatory Biologics Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Anti-inflammatory Biologics Sales Market Share by Region (2016-2021)
- 2.2.2 Global Anti-inflammatory Biologics Revenue Market Share by Region (2016-2021)
- 2.3 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Anti-inflammatory Biologics Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Anti-inflammatory Biologics Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Anti-inflammatory Biologics Estimates and Projections (2016-2027)
- 2.4.2 Europe Anti-inflammatory Biologics Estimates and Projections (2016-2027)
- 2.4.3 China Anti-inflammatory Biologics Estimates and Projections (2016-2027)
- 2.4.4 Japan Anti-inflammatory Biologics Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Anti-inflammatory Biologics Estimates and Projections (2016-2027)
- 2.4.6 India Anti-inflammatory Biologics Estimates and Projections (2016-2027)
3 Global Anti-inflammatory Biologics Competition Landscape by Players
- 3.1 Global Top Anti-inflammatory Biologics Players by Sales (2016-2021)
- 3.2 Global Top Anti-inflammatory Biologics Players by Revenue (2016-2021)
- 3.3 Global Anti-inflammatory Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-inflammatory Biologics as of 2020)
- 3.4 Global Anti-inflammatory Biologics Average Price by Company (2016-2021)
- 3.5 Manufacturers Anti-inflammatory Biologics Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Anti-inflammatory Biologics Market Size by Type
- 4.1 Global Anti-inflammatory Biologics Historic Market Review by Type (2016-2021)
- 4.1.1 Global Anti-inflammatory Biologics Sales Market Share by Type (2016-2021)
- 4.1.2 Global Anti-inflammatory Biologics Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Anti-inflammatory Biologics Price by Type (2016-2021)
- 4.2 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Anti-inflammatory Biologics Sales Forecast by Type (2022-2027)
- 4.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Anti-inflammatory Biologics Price Forecast by Type (2022-2027)
5 Global Anti-inflammatory Biologics Market Size by Application
- 5.1 Global Anti-inflammatory Biologics Historic Market Review by Application (2016-2021)
- 5.1.1 Global Anti-inflammatory Biologics Sales Market Share by Application (2016-2021)
- 5.1.2 Global Anti-inflammatory Biologics Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Anti-inflammatory Biologics Price by Application (2016-2021)
- 5.2 Global Anti-inflammatory Biologics Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Anti-inflammatory Biologics Sales Forecast by Application (2022-2027)
- 5.2.2 Global Anti-inflammatory Biologics Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Anti-inflammatory Biologics Price Forecast by Application (2022-2027)
6 North America Anti-inflammatory Biologics Market Facts & Figures
- 6.1 North America Anti-inflammatory Biologics Sales by Company
- 6.1.1 North America Anti-inflammatory Biologics Sales by Company (2016-2021)
- 6.1.2 North America Anti-inflammatory Biologics Revenue by Company (2016-2021)
- 6.2 North America Anti-inflammatory Biologics Sales Breakdown by Type
- 6.2.1 North America Anti-inflammatory Biologics Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Anti-inflammatory Biologics Sales Breakdown by Type (2022-2027)
- 6.3 North America Anti-inflammatory Biologics Sales Breakdown by Application
- 6.3.1 North America Anti-inflammatory Biologics Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Anti-inflammatory Biologics Sales Breakdown by Application (2022-2027)
7 Europe Anti-inflammatory Biologics Market Facts & Figures
- 7.1 Europe Anti-inflammatory Biologics Sales by Company
- 7.1.1 Europe Anti-inflammatory Biologics Sales by Company (2016-2021)
- 7.1.2 Europe Anti-inflammatory Biologics Revenue by Company (2016-2021)
- 7.2 Europe Anti-inflammatory Biologics Sales Breakdown by Type
- 7.2.1 Europe Anti-inflammatory Biologics Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Anti-inflammatory Biologics Sales Breakdown by Type (2022-2027)
- 7.3 Europe Anti-inflammatory Biologics Sales Breakdown by Application
- 7.3.1 Europe 133 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 133 Sales Breakdown by Application (2022-2027)
8 China Anti-inflammatory Biologics Market Facts & Figures
- 8.1 China Anti-inflammatory Biologics Sales by Company
- 8.1.1 China Anti-inflammatory Biologics Sales by Company (2016-2021)
- 8.1.2 China Anti-inflammatory Biologics Revenue by Company (2016-2021)
- 8.2 China Anti-inflammatory Biologics Sales Breakdown by Type
- 8.2.1 China Anti-inflammatory Biologics Sales Breakdown by Type (2016-2021)
- 8.2.2 China Anti-inflammatory Biologics Sales Breakdown by Type (2022-2027)
- 8.3 China Anti-inflammatory Biologics Sales Breakdown by Application
- 8.3.1 China 246 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 246 Sales Breakdown by Application (2022-2027)
9 Japan Anti-inflammatory Biologics Market Facts & Figures
- 9.1 Japan Anti-inflammatory Biologics Sales by Company
- 9.1.1 Japan Anti-inflammatory Biologics Sales by Company (2016-2021)
- 9.1.2 Japan Anti-inflammatory Biologics Revenue by Company (2016-2021)
- 9.2 Japan Anti-inflammatory Biologics Sales Breakdown by Type
- 9.2.1 Japan Anti-inflammatory Biologics Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Anti-inflammatory Biologics Sales Breakdown by Type (2022-2027)
- 9.3 Japan Anti-inflammatory Biologics Sales Breakdown by Application
- 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Anti-inflammatory Biologics Market Facts & Figures
- 10.1 Southeast Asia Anti-inflammatory Biologics Sales by Company
- 10.1.1 Southeast Asia Anti-inflammatory Biologics Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Anti-inflammatory Biologics Revenue by Company (2016-2021)
- 10.2 Southeast Asia Anti-inflammatory Biologics Sales Breakdown by Type
- 10.2.1 Southeast Asia Anti-inflammatory Biologics Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Anti-inflammatory Biologics Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Anti-inflammatory Biologics Sales Breakdown by Application
- 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Anti-inflammatory Biologics Market Facts & Figures
- 11.1 India Anti-inflammatory Biologics Sales by Company
- 11.1.1 India Anti-inflammatory Biologics Sales by Company (2016-2021)
- 11.1.2 India Anti-inflammatory Biologics Revenue by Company (2016-2021)
- 11.2 India Anti-inflammatory Biologics Sales Breakdown by Type
- 11.2.1 India Anti-inflammatory Biologics Sales Breakdown by Type (2016-2021)
- 11.2.2 India Anti-inflammatory Biologics Sales Breakdown by Type (2022-2027)
- 11.3 India Anti-inflammatory Biologics Sales Breakdown by Application
- 11.3.1 India Anti-inflammatory Biologics Sales Breakdown by Application (2016-2021)
- 11.3.2 India Anti-inflammatory Biologics Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Anti-inflammatory Biologics Business
- 12.1 AbbVie
- 12.1.1 AbbVie Corporation Information
- 12.1.2 AbbVie Business Overview
- 12.1.3 AbbVie Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 AbbVie Anti-inflammatory Biologics Products Offered
- 12.1.5 AbbVie Recent Development
- 12.2 Johnson & Johnson
- 12.2.1 Johnson & Johnson Corporation Information
- 12.2.2 Johnson & Johnson Business Overview
- 12.2.3 Johnson & Johnson Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Johnson & Johnson Anti-inflammatory Biologics Products Offered
- 12.2.5 Johnson & Johnson Recent Development
- 12.3 Amgen Inc
- 12.3.1 Amgen Inc Corporation Information
- 12.3.2 Amgen Inc Business Overview
- 12.3.3 Amgen Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Amgen Inc Anti-inflammatory Biologics Products Offered
- 12.3.5 Amgen Inc Recent Development
- 12.4 AstraZeneca PLC
- 12.4.1 AstraZeneca PLC Corporation Information
- 12.4.2 AstraZeneca PLC Business Overview
- 12.4.3 AstraZeneca PLC Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 AstraZeneca PLC Anti-inflammatory Biologics Products Offered
- 12.4.5 AstraZeneca PLC Recent Development
- 12.5 Pfizer, Inc
- 12.5.1 Pfizer, Inc Corporation Information
- 12.5.2 Pfizer, Inc Business Overview
- 12.5.3 Pfizer, Inc Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Pfizer, Inc Anti-inflammatory Biologics Products Offered
- 12.5.5 Pfizer, Inc Recent Development
- 12.6 Novartis
- 12.6.1 Novartis Corporation Information
- 12.6.2 Novartis Business Overview
- 12.6.3 Novartis Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Novartis Anti-inflammatory Biologics Products Offered
- 12.6.5 Novartis Recent Development
- 12.7 Roche
- 12.7.1 Roche Corporation Information
- 12.7.2 Roche Business Overview
- 12.7.3 Roche Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Roche Anti-inflammatory Biologics Products Offered
- 12.7.5 Roche Recent Development
- 12.8 Sun Pharmaceutical Industries Ltd
- 12.8.1 Sun Pharmaceutical Industries Ltd Corporation Information
- 12.8.2 Sun Pharmaceutical Industries Ltd Business Overview
- 12.8.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Sun Pharmaceutical Industries Ltd Anti-inflammatory Biologics Products Offered
- 12.8.5 Sun Pharmaceutical Industries Ltd Recent Development
- 12.9 Sanofi
- 12.9.1 Sanofi Corporation Information
- 12.9.2 Sanofi Business Overview
- 12.9.3 Sanofi Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Sanofi Anti-inflammatory Biologics Products Offered
- 12.9.5 Sanofi Recent Development
- 12.10 GlaxoSmithKline
- 12.10.1 GlaxoSmithKline Corporation Information
- 12.10.2 GlaxoSmithKline Business Overview
- 12.10.3 GlaxoSmithKline Anti-inflammatory Biologics Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 GlaxoSmithKline Anti-inflammatory Biologics Products Offered
- 12.10.5 GlaxoSmithKline Recent Development
13 Anti-inflammatory Biologics Manufacturing Cost Analysis
- 13.1 Anti-inflammatory Biologics Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Anti-inflammatory Biologics
- 13.4 Anti-inflammatory Biologics Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Anti-inflammatory Biologics Distributors List
- 14.3 Anti-inflammatory Biologics Customers
15 Market Dynamics
- 15.1 Anti-inflammatory Biologics Market Trends
- 15.2 Anti-inflammatory Biologics Drivers
- 15.3 Anti-inflammatory Biologics Market Challenges
- 15.4 Anti-inflammatory Biologics Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
The global Anti-inflammatory Biologics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-inflammatory Biologics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Synthetic Type
Biological Type
Segment by Application
Arthritis
Respiratory Diseases
Dermatology
Gastroenterology
Others
The Anti-inflammatory Biologics market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-inflammatory Biologics market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
AbbVie
Johnson & Johnson
Amgen Inc
AstraZeneca PLC
Pfizer, Inc
Novartis
Roche
Sun Pharmaceutical Industries Ltd
Sanofi
GlaxoSmithKline